Skip to main content
. 2021 Feb 8;115:103696. doi: 10.1016/j.jbi.2021.103696

Fig. 5.

Fig. 5

Drug repurposing for COVID-19 with the open discovery pattern DrugA-inhibits|interacts_with-ConceptBandConceptB-affects|associated_with|causes|predisposes-COVID-19. The directionality is from the periphery (the predicted drugs) through the intermediate concepts to COVID-19 in the center.